Target intelligence / Profile preview

Novel transcript, antisense to FAM101A

Molecular classification
Other (classified as a non-coding RNA/antisense transcript[1])
01

Overview

Novel transcript, antisense to FAM101A (ENSG00000308501) is a non-coding RNA located antisense to the FAM101A gene (also known as RFLNA or Refilin A), which encodes a protein involved in actin cytoskeleton organization[1][2]. The antisense nature suggests a potential regulatory relationship with FAM101A, though its biological significance, functional roles, disease associations, and relevance to pharmacology have not been characterized in the literature. This transcript is not a receptor, enzyme, or typical therapeutic target, but rather a poorly described and possibly regulatory RNA molecule[1].

Other names
Antisense to FAM101Aantisense RNA to FAM101AENSG00000308501
02

Biological functions

Other (no established biological function; potential regulatory role via antisense interaction, but not experimentally validated[1])
03

Disease associations

Other (no direct disease associations reported for this specific antisense transcript[1])

Beyond the preview

Go deeper on Novel transcript, antisense to FAM101A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to FAM101A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call